What is the Future of Panobinostat in Cancer Therapy?
The future of panobinostat in cancer therapy looks promising as ongoing research continues to evaluate its efficacy in combination with other therapeutic agents. Clinical trials are exploring its potential in synergy with immunotherapy, targeted therapies, and novel drug combinations for various cancer types. Advances in biomarker research may also help identify which patients are most likely to benefit from panobinostat, thereby personalizing cancer treatment further.
